Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Clinical trial NCT03736616 · UNKNOWN

Trial details

NCT number: NCT03736616
Sponsor: Swedish Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2019-08-16
Primary completion: 2023-09-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.